NMD-VCell Disease Virtual Cell Platform Specify a cell-state question, inspect computability, and design the missing test Module: Virtual Cell Engine · evidence-to-experiment workflow NMD = neuromuscular disorders

Current limit: the site can compare existing evidence, but no candidate has yet been independently repeated in a DMD muscle model.

Research evidence only 21 observed HepG2 perturbations 0 independent DMD replications Boundary & release
Observed HepG2 perturbations with limited external myogenic context No validated DMD perturbation prediction v1.0.0-database-resource Frozen 25 Jul 2026 Schema 1.1 Model ridge-safe-v2.3 Benchmark repeated-fold-v2.2 Build EA-20260730-34 DOI pending Open evidence boundary →

NMD-VCell · Virtual Cell Engine

Compose a disease-cell question. See what can actually be computed.

Specify the cell state, perturbation, time and endpoint. NMD-VCell returns the available evidence layer, the locked prediction layer and the experiment needed to connect them.

Current scientific boundary: evidence assembly and a limited same-assay baseline are available. Calibrated DMD perturbation response is not.

NMDVirtual
Cell
evidence-aware
Cell state Perturbation Time Phenotype Uncertainty

Question composer

Define the biological transition before asking for an answer.

Local evidence check · no model inference
01
02
03
04
05
06
Inputs assemble a research object in your browser. They do not call a disease-response model.
Current answer state Question assembled · prediction locked ZNF133 CRISPRi in DMD proliferating myoblasts can be linked to observed HepG2 response and an unperturbed human-myogenic reference, but not to a calibrated DMD state transition.
01Observed substrate21-gene HepG2 CRISPRi response matrix
02Biological context0 h human-myoblast reference
03Model taskSame-assay mean-response baseline only
04DMD truthNo independent matched outcome
MolecularLimited baselineSame-assay HepG2 only
Cell stateLockedNo conditioned DMD trajectory
FunctionLockedNo muscle functional outcome
ToxicityLockedNo matched safety readout
Cell–cellLockedNo causal cross-cell outcome
Decision-blocking gapIndependent DMD myogenic perturbation with a prespecified state endpoint

Computable biological assets

Four layers connect the atlas to a future predictor.

Inspect all five datasets →
Layer 1 · Context

Human-myogenic reference

271 cells across 0, 24, 48 and 72 hours provide a measured, unperturbed differentiation axis.

Reference available
Layer 2 · Perturbation

Observed CRISPRi substrate

Twenty-one candidates have processed same-context HepG2 response vectors; nine have qualified human-myoblast screening context.

Context bounded
Layer 3 · Model

Frozen baseline task

Simple target-held-out baselines test recovery inside one assay. Cross-cell and disease transport are separate unevaluated tasks.

Executed · limited
Layer 4 · Truth

Prospective DMD outcomes

The registered study, prediction and outcome objects needed for calibration remain empty by design.

Not yet available

State transition contract

Measured reference and desired prediction are kept visually separate.

The current platform can locate a question along myogenic time. It cannot infer the counterfactual arrow from perturbation to DMD function until matched outcomes exist.

Measured referenceMyoblast0 h
Measured referenceDifferentiate24–48 h
Context screenFusion9/21 candidates
Desired outputDMD function0 outcomes

Machine-readable product contract

The interface and its scientific ceiling are downloadable.

Use the schema to prepare a future virtual-cell run object. A valid object records modality, cell state, disease context, time, endpoint, evidence provenance and whether inference was executed.

{
  "cell_state": "proliferating_myoblast",
  "disease_context": "DMD",
  "perturbation": {"modality": "CRISPRi", "target": "ZNF133"},
  "time_hours": 48,
  "primary_endpoint": "cell_state_transition",
  "inference_status": "LOCKED_NO_DMD_OUTCOMES"
}